ArticleFrontiers in cardiovascular medicine2026
Factors associated with concurrent cardiovascular disease in patients with rheumatoid arthritis and development of machine learning models for comorbidity identification.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To analyze factors associated with concurrent cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA) and to develop machine learning models for identifying current CVD comorbidity status using routinely available clinical data. Methods: This was a cross-sectional observational study. We included 4,767 patients with RA who attended Beijing Jishuitan Hospital from January 2021 to December 2024 and met the diagnostic criteria. According to the current presence of CVD, patients were divided into an RA-CVD group ( Results: The current prevalence of CVD in patients with RA was 7.68%. Compared with the RA-non-CVD group, the RA-CVD group had a higher proportion of men, older age, longer disease duration, and higher rates of hypertension and diabetes. Several indicators reflecting inflammatory burden, renal function, metabolic status, and hematologic characteristics also differed significantly between groups. Multivariable logistic regression showed that age, male sex, and disease duration were stable factors associated with CVD in RA in the high-completeness primary model. Multiple imputation sensitivity analysis further supported the robustness of these findings. In the clinically enhanced model, age and male sex remained stably associated with CVD, whereas hypertension, diabetes, erythrocyte sedimentation rate, and estimated glomerular filtration rate did not show stable independent statistical associations. The simplified conventional-risk baseline model showed comparable discrimination to the core-variable logistic regression model, but its sensitivity was very low at the default threshold of 0.50. The non-resampled baseline model achieved an AUC of 0.78 and a PR-AUC of 0.22, with a sensitivity of 0.04 at the default threshold. Core-variable models had moderate ability to distinguish patients with and without concurrent CVD. Adding a broader set of structured variables improved model discrimination, but sensitivity remained very low at the default threshold of 0.50. Training-derived Youden-threshold adjustment improved minority-class identification. For example, the sensitivity of the wide-feature XGBoost model increased from 0.06 at the default threshold to 0.81 after training-derived threshold adjustment. Conclusion: The current presence of CVD in RA reflects a complex comorbidity pattern characterized by multiple associated clinical factors. Age, male sex, and longer disease duration were relatively stable associated factors. Within the present internally validated setting, machine learning models based on routinely available clinical data may provide preliminary support for identifying concurrent CVD status in patients with RA. Expanding the variable set and applying training-derived threshold adjustment may improve recognition of minority-class patients in this imbalanced dataset. These findings provide a preliminary data-driven framework for comorbidity-oriented cardiovascular assessment in RA, but model stability, threshold transportability, and generalizability require further validation in multicenter prospective cohorts.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.